Atovaquone treats toxoplasmocosis, which, together with genetic susceptability and other effect modifiers, may be one cause of schizophrenia. What existing data might exist to allow me to test this hypothesisi? Quick google searches suggests Atovaquone at the very least, tends not to be associated with anxiety or psychosis as side effects which for one is a good sign. Note, most schizophrenics aren't infected with toxo. they are just infected at a higher rate so it could explain a subset.